Electrospinning/electrospraying coatings for metal microneedles: A design of experiments (DOE) and quality by design (QbD) approach

被引:29
作者
Ali, Radeyah [1 ]
Mehta, Prina [1 ]
Monou, Paraskevi Kyriaki [2 ]
Arshad, Muhammad S. [1 ]
Panteris, Emmanuel [3 ]
Rasekh, Manoochehr [1 ,4 ]
Singh, Neenu [1 ]
Qutachi, Omar [1 ]
Wilson, Philippe [5 ]
Tzetzis, Dimitrios [6 ]
Chang, Ming-Wei [7 ]
Fatouros, Dimitrios G. [2 ]
Ahmad, Zeeshan [1 ]
机构
[1] De Montfort Univ, Leicester Sch Pharm, Leicester LE1 9BH, Leics, England
[2] Aristotle Univ Thessaloniki, Sch Pharm, Dept Pharmaceut Technol, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Sch Biol, Dept Bot, GR-54124 Thessaloniki, Greece
[4] Brunel Univ London, Coll Engn Design & Phys Sci, Uxbridge UB8 3PH, Middx, England
[5] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Brackenhurst Campus, Southwell NG25 0QF, England
[6] Int Hellen Univ, Sch Sci & Technol, Thermi, Greece
[7] Univ Ulster, Nanotechnol & Integrated Bioengn Ctr, Jordanstown Campus, Newtownabbey BT37 0QB, North Ireland
关键词
Electrohydrodynamic atomisation; Quality by design; Transdermal delivery; Microneedles; IN-VITRO; ELECTROHYDRODYNAMIC ATOMIZATION; TRANSDERMAL DELIVERY; DRUG-DELIVERY; FABRICATION; NANOPARTICLES; PERMEATION; RELEASE; SKIN; PVP;
D O I
10.1016/j.ejpb.2020.08.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The research presented here shows QbD implementation for the optimisation of the key process parameters in electrohydrodynamic atomisation (EHDA). Here, the electrosprayed nanoparticles and electrospun fibers consisting of a polymeric matrix and dye. Eight formulations were assessed consisting of 5% w/v of polycaprolactone (PCL) in dichloromethane (DCM) and 5% w/v polyvinylpyrrolidone (PVP) in ethanol. A full factorial DOE was used to assess the various parameters (applied voltage, deposition distance, flow rate). Further particle and fiber analysis using Scanning Electron Microscopy (SEM), Differential Scanning Calorimetry (DSC), Thermogravimetric Analysis (TGA), Fourier Transform Infrared Spectroscopy (FTIR), particle/fiber size distribution. In addition to this in vitro release studied were carried out using fluorescein and Rhodamine B as model dyes and in vitro permeation studies were applied. The results show a significant difference in the morphology of resultant structures as well as a more rapid release profile for the PVP particles and fibers in comparison to the sustained release profiles found with PCL. In vitro drug release studies showed 100% drug release after 7 days for PCL particles and showed 100% drug release within 120 min for PVP particles. The release kinetics and the permeation study showed that the MN successfully pierced the membrane and the electrospun MN coating released a large amount of the loaded drug within 6 h. This study has demonstrated the capability of these robust MNs to encapsulate a diverse range drugs within a polymeric matrix giving rise to the potential of developed personalised medical devices.
引用
收藏
页码:20 / 39
页数:20
相关论文
共 50 条
  • [31] Quality by Design (QbD) Paradigm: An Integrated Multivariate Approach to Transdermal Patch System Development
    Prajwala, S.
    Sangeetha, G.
    Swamivelmanickam, M.
    JOURNAL OF REPORTS IN PHARMACEUTICAL SCIENCES, 2024, 12 (01):
  • [32] PROCESS OPTIMIZATION USING QUALITY BY DESIGN (QBD) APPROACH OF A GENTAMICIN LOADED PLGA BIOCOMPOSITE
    Ciocilteu, Maria-Viorica
    Nicolaescu, Oana Elena
    Mocanu, Andreea Gabriela
    Nicolicescu, Claudiu
    Rau, Gabriela
    Neamtu, Johny
    Amzoiu, Emilia
    Amzoiu, Emanuel
    Oancea, Carmen
    Turcu-Stiolica, Adina
    JOURNAL OF SCIENCE AND ARTS, 2021, (04) : 1069 - 1080
  • [33] Implementation of Quality by Design (QbD) for development of bilayer tablets
    Simao, J.
    Chaudhary, S. A.
    Ribeiro, A. J.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 184
  • [34] Development of an emulgel for the treatment of rosacea using quality by design approach
    Torregrosa, Annibal
    Teresa Ochoa-Andrade, Ana
    Emma Parente, Maria
    Vidarte, Ana
    Guarinoni, Giovanna
    Savio, Eduardo
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2020, 46 (02) : 296 - 308
  • [35] Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters
    Cunha, Sara
    Costa, Claudia Pina
    Loureiro, Joana A.
    Alves, Jorge
    Peixoto, Andreia F.
    Forbes, Ben
    Sousa Lobo, Jose Manuel
    Silva, Ana Catarina
    PHARMACEUTICS, 2020, 12 (07) : 1 - 27
  • [36] A QBD WITH DESIGN-OF-EXPERIMENTS APPROACH FOR DEVELOPMENT OF A STATE-OF-THE-ART UPLC PURITY METHOD FOR CARBAMAZEPINE
    Schmidt, Alexander H.
    Wess, Carsten
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2014, 37 (18) : 2653 - 2666
  • [37] Development of immediate release Rupatadine fumarate 10 mg tablets: A Quality by Design (QbD) approach
    Castillo Henriquez, Luis
    Vargas Zuniga, Rolando
    Carazo Berrocal, Gustavo
    Madrigal Redondo, German
    Calvo Guzman, Briner
    Baltodano Viales, Eleaneth
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (10) : 1674 - 1681
  • [38] Development of Theranostic Perfluorocarbon Nanoemulsions as a Model Non-Opioid Pain Nanomedicine Using a Quality by Design (QbD) Approach
    Herneisey, Michele
    Liu, Lu
    Lambert, Eric
    Schmitz, Nicholas
    Loftus, Shannon
    Janjic, Jelena M.
    AAPS PHARMSCITECH, 2019, 20 (02)
  • [39] Formulation and Optimization of Trandolapril Oro-dispersible Tablets using the Quality by Design (QbD) Approach
    Kumar, Ganesh
    Bhatt, Meenakshi
    LETTERS IN DRUG DESIGN & DISCOVERY, 2023, 20 (09) : 1194 - 1203
  • [40] Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach
    Bhise, Ketki
    Kashaw, Sushil Kumar
    Sau, Samaresh
    Iyer, Arun K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 526 (1-2) : 506 - 515